Do survivors of childhood cancer have an increased incidence of primary ovarian insufficiency? Commentary

Nature Clinical Practice Endocrinology and Metabolism

Volumn 3, Issue 4, 2007, Pages 326-327

  Armstrong, Alicia Y ^a   Calis, Karim A ^a   Nelson, Lawrence M ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT;

CANCER RADIOTHERAPY; CANCER SURVIVOR; CHILDHOOD CANCER; EARLY MENOPAUSE; HODGKIN DISEASE; HUMAN; INCIDENCE; MENARCHE; MENSTRUAL CYCLE; NOTE; OVARY INSUFFICIENCY; PRIORITY JOURNAL; QUESTIONNAIRE; SIBLING;

EID: 33947499894     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0452     Document Type: Note

References (5)

1. Larsen EC et al. (2003) Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 88: 5307-5314
2. Bath LE et al. (2003) Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 18: 2368-2374
3. Letur-Konirsch H and Guis F (1996) Recovery of ovarian function after radiation-induced menopause. Does follicle-stimulating hormone (FSH) have a definitive prognostic value [French]? C R Acad Sci III 319: 907-912
4. Nelson LM et al. (2005) An update: spontaneous premature ovarian failure is not an early menopause. Fertil Steril 83: 1327-1332
5. Albright F et al. (1942) A syndrome characterized by primary ovarian insufficiency and decreased stature. Am J Med Sci 204: 625-648